Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

Sunstone Digital Tech continues delivering scalable, performance-driven mobile application development services built ...

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical ...

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

The Align Foundation, a nonprofit accelerating predictive biology by convening the world's leading minds to generate and optimize the data that powers AI breakthroughs, today announced a partnership ...

Data integration between IPO Prophet and PM Insights brings pre-IPO valuations and Day-1 trading intelligence together ...

We never aimed to become the biggest roofing company. Our goal was to become the most technically capable and trusted ...

Home Service Businesses Are Replacing Marketing Tactics with Marketing Leadership Pauma Valley, United States - ...